• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处方药与微生物组

Prescribed Drugs and the Microbiome.

机构信息

Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Visionsgatan 4, Stockholm 17177, Sweden; Science for Life Laboratory, Tomtebodavägen 23a, Stockholm 171 65, Sweden.

出版信息

Gastroenterol Clin North Am. 2019 Sep;48(3):331-342. doi: 10.1016/j.gtc.2019.04.002. Epub 2019 Jun 12.

DOI:10.1016/j.gtc.2019.04.002
PMID:31383274
Abstract

The interaction between drug use, the microbiome, and the host is complex and multidimensional. Drugs and the microbiota may be risk factors or protective factors for disease. These interactions may explain interpersonal variations in drug efficacy and toxicity, but also interpersonal variations in microbiota composition and functioning, and potential (long-term) side effects from drugs.

摘要

药物使用、微生物组和宿主之间的相互作用是复杂和多维的。药物和微生物群可能是疾病的危险因素或保护因素。这些相互作用可以解释药物疗效和毒性的个体间差异,也可以解释微生物群落组成和功能的个体间差异,以及药物的潜在(长期)副作用。

相似文献

1
Prescribed Drugs and the Microbiome.处方药与微生物组
Gastroenterol Clin North Am. 2019 Sep;48(3):331-342. doi: 10.1016/j.gtc.2019.04.002. Epub 2019 Jun 12.
2
Systematically investigating the impact of medication on the gut microbiome.系统地研究药物对肠道微生物群的影响。
Curr Opin Microbiol. 2017 Oct;39:128-135. doi: 10.1016/j.mib.2017.11.001.
3
Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response?药物微生物组学:药物反应变异性的圣杯?
Clin Pharmacol Ther. 2019 Aug;106(2):317-328. doi: 10.1002/cpt.1437. Epub 2019 May 7.
4
Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.药物药效微生物组学和毒效微生物组学:从零散报告到药物-微生物组相互作用的系统研究。
Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):1043-1055. doi: 10.1080/17425255.2018.1530216. Epub 2018 Oct 9.
5
Pharmacomicrobiomics and Drug-Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy.药物微生物组学与药物-感染相互作用:共生菌、共生菌和病原菌对宿主药物治疗反应的影响。
Int J Mol Sci. 2023 Dec 4;24(23):17100. doi: 10.3390/ijms242317100.
6
The Role of Pharmacogenomics: The Same Medications Do Not Work the Same on Everyone.
Nurs Clin North Am. 2016 Mar;51(1):ix-x. doi: 10.1016/j.cnur.2015.12.002. Epub 2016 Jan 13.
7
Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.微生物群-药物相互作用:对治疗药物代谢和疗效的影响。
Maturitas. 2018 Jun;112:53-63. doi: 10.1016/j.maturitas.2018.03.012. Epub 2018 Apr 5.
8
The Role of the Human Microbiome in Chemical Toxicity.人类微生物组在化学毒性中的作用。
Int J Toxicol. 2019 Jul/Aug;38(4):251-264. doi: 10.1177/1091581819849833. Epub 2019 Jun 20.
9
Microbiome as a tool and a target in the effort to address antimicrobial resistance.微生物组作为解决抗微生物药物耐药性问题的工具和目标。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12902-12910. doi: 10.1073/pnas.1717163115.
10
Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment.药物微生物组学:在抗高血压治疗中利用药物与微生物群的相互作用
Front Med (Lausanne). 2022 Jan 19;8:742394. doi: 10.3389/fmed.2021.742394. eCollection 2021.

引用本文的文献

1
Prenatal and Early Childhood Exposure to Antibiotics or Gastric Acid Inhibitors and Increased Risk of Epilepsy: A Nationwide Population-Based Study.产前及幼儿期暴露于抗生素或胃酸抑制剂与癫痫风险增加:一项基于全国人口的研究
Clin Pharmacol Ther. 2025 Jul;118(1):206-217. doi: 10.1002/cpt.3679. Epub 2025 Apr 15.
2
Prenatal and Early Childhood Exposure to Proton Pump Inhibitors and Antibiotics and the Risk of Childhood Cancer: A Nationwide Population-Based Cohort Study.产前及幼儿期暴露于质子泵抑制剂和抗生素与儿童癌症风险:一项基于全国人口的队列研究。
Drug Saf. 2025 Apr;48(4):375-388. doi: 10.1007/s40264-024-01500-x. Epub 2024 Dec 12.
3
Risk of neurodevelopmental impairment in Swedish preterm children treated for necrotizing enterocolitis: retrospective cohort study.
瑞典接受坏死性小肠结肠炎治疗的早产儿发生神经发育障碍的风险:回顾性队列研究。
BJS Open. 2024 Oct 29;8(6). doi: 10.1093/bjsopen/zrae131.
4
The Diagnosis of Intestinal Fibrosis in Crohn's Disease-Present and Future.克罗恩病肠纤维化的诊断——现状与未来。
Int J Mol Sci. 2024 Jun 25;25(13):6935. doi: 10.3390/ijms25136935.
5
Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population-based cohort study.孕期及产后抑郁症期间使用抗生素或胃酸抑制剂:基于人群的队列研究。
Acta Obstet Gynecol Scand. 2024 Aug;103(8):1596-1605. doi: 10.1111/aogs.14864. Epub 2024 Jun 3.
6
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study.艰难梭菌复发在癌症患者和非癌症患者中的差异:一项基于瑞典人群的队列研究。
Infection. 2024 Apr;52(2):649-660. doi: 10.1007/s15010-024-02193-1. Epub 2024 Feb 26.
7
Modulation of the Gut Microbiota by Nutrition and Its Relationship to Epigenetics.营养对肠道微生物群的调节及其与表观遗传学的关系。
Int J Mol Sci. 2024 Jan 19;25(2):1228. doi: 10.3390/ijms25021228.
8
The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence.系统抗生素和质子泵抑制剂联合应用对艰难梭菌感染和复发的影响。
J Antimicrob Chemother. 2024 Mar 1;79(3):608-616. doi: 10.1093/jac/dkae012.
9
Non-antibiotic compounds associated with humans and the environment can promote horizontal transfer of antimicrobial resistance genes.非抗生素化合物与人类和环境有关,可促进抗菌药物耐药基因的水平转移。
Crit Rev Microbiol. 2024 Nov;50(6):993-1010. doi: 10.1080/1040841X.2023.2233603. Epub 2023 Jul 18.
10
Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden.质子泵抑制剂维持治疗与瑞典全因及特定原因死亡率增加相关。
Dig Dis Sci. 2023 Jun;68(6):2252-2263. doi: 10.1007/s10620-023-07820-9. Epub 2023 Jan 11.